Ortanol (Omeprazole)

Omeprazole, the active ingredient in Ortanol, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children when appropriate.

GNH USA supplies Ortanol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole belongs to the proton pump inhibitor class and is used to manage disorders caused by excess gastric acid. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Erosive esophagitis: heals inflamed esophageal lining caused by acid exposure. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder. - NSAID‑induced ulcer prophylaxis: lowers the chance of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be self‑limiting. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness that may improve with food. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements or hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing requiring immediate care. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: extensive skin blistering and detachment. - Elevated liver enzymes: signs of hepatic stress detectable in blood tests. - Hypomagnesemia: low magnesium levels that can cause muscle cramps or cardiac arrhythmia. - Increased risk of bone fracture: long‑term use may affect calcium balance.

Before initiating therapy, consider patient‑specific factors and monitor appropriately. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment evaluation: use caution in moderate to severe liver disease. - Elderly patients: monitor for increased sensitivity to side effects. - Long‑term therapy: periodic review of necessity and possible nutrient deficiencies. - Concomitant medication review: check for interactions that may alter drug effectiveness. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several other medicines.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption when taken together. - Atazanavir: decreased antiviral efficacy due to lowered gastric acidity. - Clopidogrel: diminished antiplatelet activation, potentially reducing cardiovascular protection.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in anticoagulant effect, requiring INR monitoring. - Digoxin: altered serum levels may necessitate dosage adjustment.